Have you used prednisone recently?
NCCR has multiple studies requiring the use of prednisone for an asthma worsening over the last 12 to 18 months. Please call Teresa at 919-881-0309.
Asthma
Asthma study for subjects currently using Nucula or Fasenra as part of their asthma treatment
- Ages 12 years old & Up
- Currently using a daily maintenance inhaler
- Everyone receives active study medication
- Lifetime Nonsmoker or nonsmoker for 6 months with limited smoking history
- Willing to complete 15 visits over 15 months
- Study related care and study medication at no cost
- Compensation for qualified participants is up to $1710
Asthma
Asthma study evaluating a new combination inhaler
- Ages 12 – 80 years old
- Currently using a daily maintenance inhaler
- Everyone receives active study medication (No chance of Placebo)
- Lifetime Nonsmoker or nonsmoker for 6 months with limited smoking history
- Willing to complete 8 visits over 28 weeks
- Study related care and study medication at no cost
- Continue on your current inhaler
- Compensation for qualified participants is $1500-$2300
Asthma
Asthma study evaluating a new Generic Albuterol
- Ages 18 – 65 years old
- Currently using a low dose daily maintenance inhaler ( Flovent, Arnuity, Pulmicort, QVAR or Asmanex)
- Lifetime Nonsmokers or nonsmoker for 6 months with very limited smoking history
- Willing to complete 7 visits over 6 weeks
- Study related care and study medication at no cost
- Compensation for qualified participants is up to $700
Asthma
Asthma study evaluating a new combination inhaler
- Ages 12 – 80 years old
- Currently using a daily maintenance inhaler
- Everyone receives active study medication (No chance of Placebo)
- Lifetime Nonsmoker or nonsmoker for 6 months with limited smoking history
- Willing to complete 15 visits over 28 – 52 weeks
- Study related care and study medication at no cost
- Compensation for qualified participants up to $1,000
Asthma
Adult asthma study evaluating a new “Add on medication”
- Ages 18 years old and Up
- Lifetime Nonsmoker or nonsmoker for 6 months with limited smoking history
- Willing to complete 10 visits over 34 weeks
- Study related care and study medication at no cost
- Compensation for qualified participants is up to $1225
Asthma
Adult asthma study evaluating a new “Add on” inhaler
- Ages 18 – 75 years old
- Lifetime Nonsmoker or nonsmoker for 6 months with limited smoking history
- Study medication is an “Add On” inhaler
- Participants will remain on their current maintenance inhaled steroid treatment
- Willing to complete 11 visits over 30 weeks
- Study related care and study medication at no cost
- Compensation for qualified participants is up to $1760
COPD
COPD study evaluating 2 FDA approved treatments:
Spiriva Dry Powder or Revefenacin by jet nebulizer
- Ages 40 years old and up
- Current or former smoker
- Willing to complete 5 visits over approx. 13 weeks
- Study related care and study medication at no cost
- Compensation for qualified participants is up to $410
COPD
COPD study evaluating a new Generic Atrovent
- Ages 40 years old and up
- Current or former smoker
- Willing to complete 4-5 visits over 25 – 55 days
- Study related care and study medication at no cost
- Compensation for qualified participants is up to $850
MIGRAINE HEADACHE
Migraine study evaluating a new investigational medicine for acute treatment of migraines.
- Ages 18 to 65 years
- Have had migraines for at least 1 year
- Have 2 to 8 migraine attacks each month
- Have less than 15 headache days each month
- Study related care and study medication at no cost
- Compensation for qualified participants is up to $300 (additional compensation for compliant diary assessments)
MIGRAINE HEADACHE
Migraine study to investigate the efficacy and safety of 2 FDA approved medications for acute treatment of migraines.
- Ages 18 to 65 years
- Have had migraines for at least 1 year with onset prior to age 50
- Have an average of 2 migraine attacks per month over the past 3 months
- Have an average of 4 to 14 migraine headache days per month over the past 3 months
- Body Mass Index (BMI) <40kg/m2
- Study related care and study medication at no cost
- Compensation for qualified participants up to $840